Innovent Biologics (HK:1801) has released an update.
Innovent Biologics, Inc. has announced its upcoming Annual General Meeting (AGM) to be held on June 21, 2024, where it will present the audited financial statements, re-elect directors, and decide on directors’ remuneration. Key resolutions include re-appointing their external auditor and seeking approval for a share buy-back program not exceeding 10% of the issued shares. The meeting will take place at the company’s Yale meeting room in the Suzhou Industrial Park, China.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
